Incidence of anxiety and depression in a predominantly HIV-infected population with severe adverse drug reactions

Journal Article

2014

Permanent link to this Item
http://hdl.handle.net/11427/15404
 http://dx.doi.org/10.1186/2045-7022-4-S3-P95
Files
Zitha_Incidence_of_anxiety_2014.pdf (199.44 KB)
Authors
Zitha, Eddy
Chiliza, Bonga
Muloiwa, Rudzani
Lehloenya, Rannakoe
Journal Title

Clinical and Translational Allergy

Link to Journal
http://www.ctajournal.com/
Journal ISSN
Volume Title
Publisher

BioMed Central Ltd

Publisher

University of Cape Town

Department
Department of Paediatrics and Child Health
Faculty
Faculty of Health Sciences
License

http://creativecommons.org/licenses/by/4.0.

Series
Abstract
Little is known on the short-term or medium-term psychological and psychiatric sequelae following Stevens Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) and drug reaction with eosinophilia and systemic symptoms (DRESS). Based on this we did a prospective study designed to assess anxiety and depression in patients with severe cutaneous adverse drug reactions by indicating higher Hospital anxiety and depression scale (HADS).
Description
Keywords
psychological and psychiatric sequelae
Stevens Johnson syndrome (SJS)
toxic epidermal necrolysis (TEN)
drug reaction with eosinophilia and systemic symptoms (DRESS)

Reference:

Zitha, E., Chiliza, B., Muloiwa, R., & Lehloenya, R. (2014). Incidence of anxiety and depression in a predominantly HIV-infected population with severe adverse drug reactions. Clinical and Translational Allergy, 4(Suppl 3), P95.

Collections
Journal Articles